CELL INTELLIGENCE · 肿瘤细胞治疗研究

塑造前列腺癌诊疗的未来：基因与细胞疗法的前景与陷阱

Shaping the Future of Prostate Cancer Care: The Promise and Pitfalls of Gene- and Cell-Based Therapeutics.

唑来膦酸增强 PSMA CAR-T 细胞对骨肿瘤的抗肿瘤疗效，但削弱其控制小鼠前列腺癌转移的能力

Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate can

前列腺癌的协同靶向策略

Synergistic targeting strategies for prostate cancer.

装载 CXCL9 和 IL15 的溶瘤腺病毒显示强效抗肿瘤活性并增强前列腺癌 CAR-T 治疗

Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer.

利用间充质干细胞外泌体递送治疗性 MicroRNA-let-7c 靶向去势抵抗性前列腺癌

Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.

MSC 来源的外泌体可作为靶向 CRPC 的 let-7c 治疗性递送系统。